Geisinger Wyoming Valley Medical Center

Geisinger Wyoming Valley Medical Center was paid $380K by Medicaid between Nov 2020 and Dec 2024, across 60 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 17% of everything it billed.

Compared with peers

Next to other General Acute Care Hospital providers in Pennsylvania

Rank by total paid#111 of 154

Median peer was paid$2.82M

This provider vs. median0.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	155	$5K
2021	8,784	$163K
2022	3,304	$129K
2023	2,620	$70K
2024incomplete	317	$13K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	17%	765	746	$63K
0202U	Oncology (prostate), multianalyte, gene expression profiling	16%	247	247	$60K
87631		9.2%	250	246	$35K
87481		7.6%	418	378	$29K
84443	Thyroid stimulating hormone (TSH)	7.3%	1,237	1,201	$28K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	4.8%	163	159	$18K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	4.2%	680	660	$16K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	4.1%	419	409	$16K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	3.7%	630	610	$14K
80061	Lipid panel	2.9%	831	819	$11K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	2.6%	698	681	$10K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	1.7%	165	164	$6K

48 more codes

88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	1.6%	205	$6K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.3%	62	$5K
83036	Hemoglobin; glycosylated (A1C)	1.2%	714	$5K
80053	Comprehensive metabolic panel	1.2%	396	$4K
71046	Radiologic examination, chest; 2 views	1.1%	233	$4K
36415	Collection of venous blood by venipuncture	1.0%	2,348	$4K
87430		<1%	575	$4K
87086	Culture, bacterial; quantitative colony count, urine	<1%	439	$3K
87150		<1%	83	$3K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	41	$3K
82607		<1%	232	$3K
87511		<1%	141	$3K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	99	$3K
82728		<1%	171	$2K
86803		<1%	102	$2K
85027		<1%	249	$2K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	315	$2K
86618		<1%	73	$2K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	46	$2K
83540		<1%	166	$1K
76830	Ultrasound, transvaginal	<1%	16	$1K
84439		<1%	128	$1K
84702		<1%	60	$939.74
86762		<1%	43	$828.51
83550		<1%	164	$809.32
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	14	$768.05
80048	Basic metabolic panel (calcium, ionized)	<1%	86	$721.14
86850		<1%	82	$688.95
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	25	$682.33
86592		<1%	167	$676.38
87340		<1%	37	$521.50
83735		<1%	58	$430.86
86900		<1%	95	$395.56
86901		<1%	95	$392.67
86140		<1%	101	$308.19
82746		<1%	25	$306.72
85610		<1%	62	$261.16
85652		<1%	83	$251.97
73630		<1%	14	$238.73
82570		<1%	27	$163.43
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	423	$149.73
83525		<1%	12	$139.92
82565		<1%	18	$123.42
86431		<1%	13	$95.06
85046		<1%	13	$79.40
84550		<1%	14	$78.47
J7050	Infusion, normal saline solution, 250 cc	<1%	100	$31.11
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBUCKLEY, JOHN (CAO)